Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D 24'000 IU Supplementation
NCT03920150Phase 3Completed
- Sponsor
- University Hospital Basel
- Start
- Sep 2019
- Primary completion
- May 2020
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of vitamin d in Vitamin D deficiency (VDD) (3 arms), sponsored by University Hospital Basel. Primary endpoint: Serum level of vitamin D at 3 months. Started Sep 2019; status: completed.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT03920150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03920150.